» Articles » PMID: 31008928

A Case Report on Metastatic Ileal Neuroendocrine Neoplasm to the Breast Masquerading As Primary Breast Cancer: A Diagnostic Challenge and Management Dilemma

Overview
Specialty General Medicine
Date 2019 Apr 23
PMID 31008928
Citations 2
Authors
Affiliations
Soon will be listed here.
Abstract

Rationale: Metastatic neuroendocrine neoplasms (NENs) to the breast are very rare entities comprising only 1% to 2% of all metastatic breast tumors. In this article, we describe a case of a neuroendocrine ileal neoplasm metastatic to breast and liver, with breast metastatic tumor to be the initial manifestation of the disease.

Patient Concerns: We herein report a rare case of a female patient admitted to our department with a palpable painful mass on her left breast.

Diagnosis: The surgical and histological investigation revealed a metastatic neuroendocrine neoplasm to the breast originated from terminal ileum.

Interventions: A left lumpectomy, right hemicolectomy, cholecystectomy, left hepatectomy along with liver metastasectomies (V, VI, VIII) plus radiofrequency ablation of lesions to the right liver lobe plus standard lymphadenectomy was performed.

Outcomes: Considering the advanced stage of the disease, the patient received an adjuvant therapy of somatostatin analog plus everolimus. Under the guidance of oncological consultation, patients follow-up with CT and MRI scan and clinical re-evaluations in the first 3 and 6 months, substantiates no evidence of recurrence and she presents herself asymptomatic.

Lessons: An appropriate level of suspicion and selective immunohistochemistry in these cases, particularly where no prior history of a known primary neuroendocrine neoplasm occurs, may help to diagnose a previously undetected neuroendocrine tumor elsewhere in the body and provide guidance for the appropriate treatment selection.

Citing Articles

Neuroendocrine Tumor Metastases to the Breast: A Case Report and Review of the Literature.

Urrego Diaz J, Gonzalez M, Romero-Rojas A, Strosberg J, Jimenez-Vasquez P Cureus. 2023; 15(6):e40703.

PMID: 37485220 PMC: 10359153. DOI: 10.7759/cureus.40703.


The Application of Whole-Process Case Management in Patients with Triple-Negative Breast Cancer.

Zhao Y, Zhu R, Bai J, Li J, Jia X, Wang P J Oncol. 2022; 2022:1794288.

PMID: 35342395 PMC: 8942700. DOI: 10.1155/2022/1794288.

References
1.
Kashlan R, Powell R, Nolting S . Carcinoid and other tumors metastatic to the breast. J Surg Oncol. 1982; 20(1):25-30. DOI: 10.1002/jso.2930200107. View

2.
Nielsen M, Andersen J, Henriksen F, Kristensen P, Lorentzen M, Ravn V . Metastases to the breast from extramammary carcinomas. Acta Pathol Microbiol Scand A. 1981; 89(4):251-6. DOI: 10.1111/j.1699-0463.1981.tb00218.x. View

3.
Upalakalin J, Collins L, Tawa N, Parangi S . Carcinoid tumors in the breast. Am J Surg. 2006; 191(6):799-805. DOI: 10.1016/j.amjsurg.2005.10.021. View

4.
Bohman L, Bassett L, Gold R, VOET R . Breast metastases from extramammary malignancies. Radiology. 1982; 144(2):309-12. DOI: 10.1148/radiology.144.2.7089284. View

5.
Perry K, Reynolds C, Rosen D, Edgerton M, Albarracin C, Gilcrease M . Metastatic neuroendocrine tumour in the breast: a potential mimic of in-situ and invasive mammary carcinoma. Histopathology. 2011; 59(4):619-30. DOI: 10.1111/j.1365-2559.2011.03940.x. View